Shalki Choudhary

911 total citations
38 papers, 641 citations indexed

About

Shalki Choudhary is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Shalki Choudhary has authored 38 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Organic Chemistry and 11 papers in Computational Theory and Mathematics. Recurrent topics in Shalki Choudhary's work include Computational Drug Discovery Methods (11 papers), Synthesis and biological activity (8 papers) and Aldose Reductase and Taurine (7 papers). Shalki Choudhary is often cited by papers focused on Computational Drug Discovery Methods (11 papers), Synthesis and biological activity (8 papers) and Aldose Reductase and Taurine (7 papers). Shalki Choudhary collaborates with scholars based in India, Finland and Italy. Shalki Choudhary's co-authors include Om Silakari, Pankaj Kumar Singh, Himanshu Verma, Mohit Arora, Harpreet Singh, Bharti Sapra, Malkeet Singh Bahia, Om Silakari, Manjinder Singh and Himanshu Verma and has published in prestigious journals such as Life Sciences, European Journal of Pharmacology and European Journal of Medicinal Chemistry.

In The Last Decade

Shalki Choudhary

35 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shalki Choudhary India 13 210 192 116 96 91 38 641
Maha M. Abdel‐Fattah Egypt 19 271 1.3× 314 1.6× 56 0.5× 125 1.3× 106 1.2× 58 902
Chunping Wan China 16 188 0.9× 282 1.5× 58 0.5× 36 0.4× 112 1.2× 53 756
Amy Q. Wang United States 17 110 0.5× 390 2.0× 98 0.8× 80 0.8× 149 1.6× 31 1.1k
Onur Bender Türkiye 14 67 0.3× 222 1.2× 103 0.9× 58 0.6× 54 0.6× 24 630
Guanghao Zhu China 12 108 0.5× 225 1.2× 110 0.9× 186 1.9× 48 0.5× 49 608
Alessandro De Leo Italy 17 203 1.0× 218 1.1× 108 0.9× 46 0.5× 66 0.7× 34 778
Sowjanya Thatikonda India 17 209 1.0× 294 1.5× 62 0.5× 34 0.4× 56 0.6× 27 857
Subrata Deb United States 18 54 0.3× 431 2.2× 137 1.2× 44 0.5× 55 0.6× 53 1.0k
Shanyi Li United States 18 60 0.3× 528 2.8× 289 2.5× 67 0.7× 51 0.6× 34 1.2k
Hsiao‐Chen Dina Kuo United States 15 61 0.3× 506 2.6× 290 2.5× 67 0.7× 47 0.5× 26 1.0k

Countries citing papers authored by Shalki Choudhary

Since Specialization
Citations

This map shows the geographic impact of Shalki Choudhary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shalki Choudhary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shalki Choudhary more than expected).

Fields of papers citing papers by Shalki Choudhary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shalki Choudhary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shalki Choudhary. The network helps show where Shalki Choudhary may publish in the future.

Co-authorship network of co-authors of Shalki Choudhary

This figure shows the co-authorship network connecting the top 25 collaborators of Shalki Choudhary. A scholar is included among the top collaborators of Shalki Choudhary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shalki Choudhary. Shalki Choudhary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choudhary, Shalki, et al.. (2025). Dapsone‐Induced Hypersensitivity Pneumonitis in Borderline Tuberculoid Leprosy. International Journal of Dermatology. 65(3). 674–676.
2.
Choudhary, Shalki, Vaskuri G. S. Sainaga Jyothi, D. Bahuguna, et al.. (2024). Etodolac utility in osteoarthritis: drug delivery challenges, topical nanotherapeutic strategies and potential synergies. Therapeutic Delivery. 15(12). 977–995. 2 indexed citations
3.
Mittal, Mona, Ashish Saini, Preetam Singh, et al.. (2024). Affordable excellence: unveiling the potential of graphitic carbon-based counter electrodes for high-performance dye-sensitized solar cells. Digest Journal of Nanomaterials and Biostructures. 19(4). 1975–1985.
4.
Ojha, Prasanta Kumar, et al.. (2023). Magnetic ordering in sol-gel-based Tm3Fe5O12 thin film. Materials Letters. 352. 135154–135154. 1 indexed citations
5.
Verma, Himanshu, et al.. (2023). Identification of natural peptides from “PlantPepDB” database as anti-SARS-CoV-2 agents: A protein-protein docking approach. Phytomedicine Plus. 3(2). 100446–100446. 1 indexed citations
6.
7.
Verma, Himanshu, et al.. (2022). Network Analysis Guided Designing of Multi-Targeted Anti-Fungal Agents: Synthesis and Biological Evaluation. Journal of Molecular Structure. 1272. 134128–134128. 6 indexed citations
8.
Choudhary, Shalki, et al.. (2021). Von Willebrand factor: A key glycoprotein involved in thrombo-inflammatory complications of COVID-19. Chemico-Biological Interactions. 348. 109657–109657. 11 indexed citations
9.
Choudhary, Shalki, et al.. (2021). Benzimidazole based hybrids against complex diseases: A catalogue of the SAR profile. European Journal of Pharmacology. 899. 174027–174027. 32 indexed citations
10.
Choudhary, Shalki, et al.. (2020). Pharmacophore-based designing of putative ROS-1 targeting agents for NSCLC. Molecular Diversity. 25(2). 1091–1102. 8 indexed citations
11.
12.
Choudhary, Shalki, Pankaj Kumar Singh, Himanshu Verma, et al.. (2020). Search for non-acidic ALR2 inhibitors: Evaluation of flavones as targeted agents for the management of diabetic complications. Bioorganic Chemistry. 96. 103570–103570. 12 indexed citations
13.
Choudhary, Shalki, et al.. (2020). The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options. Microbial Pathogenesis. 150. 104673–104673. 119 indexed citations
14.
Choudhary, Shalki, et al.. (2020). QM/MM analysis, synthesis and biological evaluation of epalrestat based mutual-prodrugs for diabetic neuropathy and nephropathy. Bioorganic Chemistry. 108. 104556–104556. 13 indexed citations
15.
Singh, Pankaj Kumar, Shalki Choudhary, Himanshu Verma, et al.. (2019). An exhaustive compilation on chemistry of triazolopyrimidine: A journey through decades. Bioorganic Chemistry. 88. 102919–102919. 27 indexed citations
16.
Verma, Himanshu, Malkeet Singh Bahia, Shalki Choudhary, Pankaj Kumar Singh, & Om Silakari. (2019). Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it. Drug Metabolism Reviews. 51(2). 196–223. 47 indexed citations
17.
Choudhary, Shalki & Om Silakari. (2019). hCES1 and hCES2 mediated activation of epalrestat-antioxidant mutual prodrugs: Unwinding the hydrolytic mechanism using in silico approaches. Journal of Molecular Graphics and Modelling. 91. 148–163. 11 indexed citations
18.
Choudhary, Shalki, et al.. (2018). Identification of 2‐benzoxazolinone derivatives as lead against molecular targets of diabetic complications. Chemical Biology & Drug Design. 92(6). 1981–1987. 10 indexed citations
19.
Choudhary, Shalki, Om Silakari, & Pankaj Kumar Singh. (2018). New Insights into Chemistry and Biological Potential of Thiazine Scaffold: A Review. Mini-Reviews in Medicinal Chemistry. 18. 2 indexed citations
20.
Choudhary, Shalki, Pankaj Kumar Singh, Himanshu Verma, Harpreet Singh, & Om Silakari. (2018). Success stories of natural product-based hybrid molecules for multi-factorial diseases. European Journal of Medicinal Chemistry. 151. 62–97. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maha M. Abdel‐Fattah Breakdown of academic impact, for papers by Chunping Wan Breakdown of academic impact, for papers by Amy Q. Wang Breakdown of academic impact, for papers by Onur Bender Breakdown of academic impact, for papers by Guanghao Zhu Breakdown of academic impact, for papers by Alessandro De Leo Breakdown of academic impact, for papers by Sowjanya Thatikonda Breakdown of academic impact, for papers by Subrata Deb Breakdown of academic impact, for papers by Shanyi Li Breakdown of academic impact, for papers by Hsiao‐Chen Dina Kuo
Rankless by CCL
2026